FTO and obesity: Mechanisms of association

Current Diabetes Reports

Volumn 14, Issue 5, 2014, Pages

  Zhao, Xu ^a,b   Yang, Ying ^a,b   Sun, Bao Fa ^a   Zhao, Yong Liang ^a   Yang, Yun Gui ^a,b  

^a Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Epitranscriptome; FTO; Obesity; RNA methylation

Indexed keywords

IRON; MESSENGER RNA; RNA; SINGLE STRANDED DNA; SINGLE STRANDED RNA; FTO PROTEIN, HUMAN; FTO PROTEIN, MOUSE; LYASE; MIXED FUNCTION OXIDASE; PROTEIN;

ADIPOSE TISSUE; ALLELE; BREAST; BREAST CANCER; CANCER RISK; DEMETHYLATION; ENERGY EXPENDITURE; ENERGY METABOLISM; ENZYME ACTIVITY; FTO GENE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; KIDNEY CANCER; LUNG CANCER; MEDIOBASAL HYPOTHALAMUS; NEOPLASM; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PANCREAS CANCER; PHYSICAL ACTIVITY; REVIEW; RNA METHYLATION; RNA PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; FEMALE; GENETIC EPIGENESIS; GENETICS; MALE; METABOLIC DISORDER; MOUSE; PATHOPHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; EPIGENESIS, GENETIC; FEMALE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; METABOLIC DISEASES; MICE; MIXED FUNCTION OXYGENASES; NEOPLASMS; OBESITY; OXO-ACID-LYASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RNA, MESSENGER;

EID: 84899129580     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-014-0486-0     Document Type: Review

References (94)

1. Morabia A, Abel T. The WHO report "Preventing chronic diseases: a vital investment" and us. Soz Praventivmed. 2006;51:74. (Pubitemid 43923170)
2. Herrera BM, Keildson S, Lindgren CM. Genetics and epigenetics of obesity. Maturitas. 2011;69:41-9.
3. • Dai HJ, Wu JC, Tsai RT, et al. T-HOD: a literature-based candidate gene database for hypertension, obesity and diabetes. Database. 2013;2013:bas061. The authors established the T-HOD database providing the most detailed summary of obesity associated gene loci and polymorphisms uncovered to date.
4. Rankinen T, Zuberi A, Chagnon YC, et al. The human obesity gene map: the 2005 update. Obesity. 2006;14:529-644. (Pubitemid 46219737)
5. Loos RJ, Bouchard C. FTO: the first gene contributing to common forms of human obesity. Obes Rev. 2008;9:246-50. (Pubitemid 351550693)
6. Scuteri A, Sanna S, Chen WM, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3:e115.
7. Hinney A, Nguyen TT, Scherag A, et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS One. 2007;2:e1361.
8. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889-94. (Pubitemid 46764279)
9. Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39:724-6. (Pubitemid 46848595)
10. Yang J, Loos RJ, Powell JE, et al. FTO genotype is associated with phenotypic variability of body mass index. Nature. 2012;490:267-72.
11. Wojciechowski P, Lipowska A, Rys P, et al. Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis. Diabetologia. 2012;55:2636-45.
12. Speakman JR, Rance KA, Johnstone AM. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity. 2008;16:1961-5.
13. Speakman JR. FTO effect on energy demand vs food intake. Nature. 2010;464:E1; discussion E2.
14. Wardle J, Llewellyn C, Sanderson S, et al. The FTO gene and measured food intake in children. Int J Obes. 2009;33:42-5.
15. Cecil JE, Tavendale R, Watt P, et al. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med. 2008;359:2558-66.
16. de Luis DA, Aller R, Conde R, et al. The rs9939609 gene variant in FTO modified the metabolic response of weight loss after a 3-month intervention with a hypocaloric diet. J Investig Med. 2013;61:22-6.
17. Haupt A, Thamer C, Staiger H, et al. Variation in the FTO gene influences food intake but not energy expenditure. Exp Clin Endocrinol Diabetes. 2009;117:194-7.
18. Li H, Wu Y, Loos RJ, et al. Variants in the fat mass- and obesity-associated (FTO) gene are not associated with obesity in a Chinese Han population. Diabetes. 2008;57:264-8.
19. Chang YC, Liu PH, Lee WJ, et al. Common variation in the fat mass and obesity-associated (FTO) gene confers risk of obesity and modulates BMI in the Chinese population. Diabetes. 2008;57:2245-52.
20. Cheung CY, Tso AW, Cheung BM, et al. Obesity susceptibility genetic variants identified from recent genome-wide association studies: implications in a Chinese population. J Clin Endocrinol Metab. 2010;95:1395-403.
21. Tews D, Fischer-Posovszky P, Wabitsch M. Regulation of FTO and FTMexpression during human pre-adipocyte differentiation. Horm Metab Res. 2011;43:17-21.
22. Wahlen K, Sjolin E, Hoffstedt J. The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis. J Lipid Res. 2008;49:607-11.
23. Lappalainen T, Kolehmainen M, Schwab U, et al. Gene expression of FTO in human subcutaneous adipose tissue, peripheral blood mononuclear cells and adipocyte cell line. J Nutrigenet Nutrigenomics. 2010;3:37-45.
24. Grunnet LG, Nilsson E, Ling C, et al. Regulation and function of FTO mRNA expression in human skeletal muscle and subcutaneous adipose tissue. Diabetes. 2009;58:2402-8.
25. Kloting N, Schleinitz D, Ruschke K, et al. Inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans. Diabetologia. 2008;51:641-7.
26. Labayen I, Ruiz JR, Ortega FB, et al. Association between the FTO rs9939609 polymorphism and leptin in European adolescents: a possible link with energy balance control. The HELENA study. Int J Obes. 2011;35:66-71.
27. Timpson NJ, Emmett PM, Frayling TM, et al. The fat mass- and obesity-associated locus and dietary intake in children. Am J Clin Nutr. 2008;88:971-8.
28. Zeggini E, Weedon MN, Lindgren CM, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316:1336-41. (Pubitemid 46871654)
29. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341-5. (Pubitemid 46871655)
30. Samaras K, Botelho NK, Chisholm DJ, et al. Subcutaneous and visceral adipose tissue FTO gene expression and adiposity, insulin action, glucose metabolism, and inflammatory adipokines in type 2 diabetes mellitus and in health. Obes Surg. 2010;20:108-13.
31. Li T,Wu K, You L, et al. Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome. PLoS One. 2013;8:e66250.
32. Li X, Liang L, Zhang M, et al. Obesity-related genetic variants, human pigmentation, and risk of melanoma. Hum Genet. 2013.
33. Iles MM, Law MH, Stacey SN, et al. A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet. 2013;45:428-32, 432e1.
34. Kaklamani V, Yi N, Sadim M, et al. The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet. 2011;12:52.
35. Lurie G, Gaudet MM, Spurdle AB, et al. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS One. 2011;6:e16756.
36. Delahanty RJ, Beeghly-Fadiel A, Xiang YB, et al. Association of obesity-related genetic variants with endometrial cancer risk: a report from the Shanghai Endometrial Cancer Genetics Study. Am J Epidemiol. 2011;174:1115-26.
37. Tang H, Dong X, Hassan M, et al. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:779-92.
38. Pierce BL, Austin MA, Ahsan H. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data. Cancer Causes Control. 2011;22:877-83.
39. Meyer TE, Boerwinkle E, Morrison AC, et al. Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study. Cancer Epidemiol Biomarkers Prev. 2010;19:558-65.
40. Lewis SJ, Murad A, Chen L, et al. Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk. PLoS One. 2010;5:e13485.
41. Tarabra E, Actis GC, Fadda M, et al. The obesity gene and colorectal cancer risk: a population study in Northern Italy. Eur J Intern Med. 2012;23:65-9.
42. Nock NL, Plummer SJ, Thompson CL, et al. FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans. Carcinogenesis. 2011;32:748-56.
43. Brennan P, McKay J, Moore L, et al. Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol. 2009;38:971-5.
44. Li GQ, Chen QW, Wang L, et al. Association between FTO gene polymorphism and cancer risk: evidence from 16,277 cases and 31, 153 controls. Tumor Biol. 2012;33:1237-43.
45. Ho AJ, Stein JL, Hua X, et al. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A. 2010;107:8404-9.
46. Keller L, Xu W, Wang HX, et al. The obesity related gene, FTO, interacts with APOE, and is associated with Alzheimer's disease risk: a prospective cohort study. J Alzheimers Dis. 2011;23:461-9.
47. Fischer J, Koch L, Emmerling C, et al. Inactivation of the FTO gene protects from obesity. Nature. 2009;458:894-8.
48. Tews D, Fischer-Posovszky P, Fromme T, et al. FTO deficiency induces UCP-1 expression and mitochondrial uncoupling in adipocytes. Endocrinology. 2013.
49. Gao X, Shin YH, Li M, et al. The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice. PLoS One. 2010;5:e14005.
50. Church C, Lee S, Bagg EA, et al. A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genet. 2009;5:e1000599.
51. Church C, Moir L, McMurray F, et al. Overexpression of FTO leads to increased food intake and results in obesity. Nat Genet. 2010;42:1086-92.
52. McMurray F, Church CD, Larder R, et al. Adult onset global loss of the FTO gene alters body composition and metabolism in the mouse. PLoS Genet. 2013;9:e1003166.
53. •• Hess ME, Hess S, Meyer KD, et al. The fat mass and obesity associated gene (FTO) regulates activity of the dopaminergic midbrain circuitry. Nat Neurosci. 2013;16:1042-8. These authors reported, for the first time, that FTO regulates the demethylation of specific mRNAs in vivo and dopaminergic transmission activity.
54. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci. 2010;13:635-41.
55. Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet. 2001;357:354-7. (Pubitemid 32128542)
56. Wu Q, Saunders RA, Szkudlarek-Mikho M, et al. The obesity-associated FTO gene is a transcriptional co-activator. Biochem Biophys Res Commun. 2010;401:390-5.
57. Kirkpatrick CL, Marchetti P, Purrello F, et al. Type 2 diabetes susceptibility gene expression in normal or diabetic sorted human alpha and beta cells: correlations with age or BMI of islet donors. PLoS One. 2010;5:e11053.
58. Poritsanos NJ, Lew PS, Mizuno TM. Relationship between blood glucose levels and hepatic FTO mRNA expression in mice. Biochem Biophys Res Commun. 2010;400:713-7.
59. Berulava T, Ziehe M, Klein-Hitpass L, et al. FTO levels affect RNA modification and the transcriptome. Eur J Hum Genet. 2012;21:317-23.
60. Tung YC, Ayuso E, Shan X, et al. Hypothalamic-specific manipulation of FTO, the ortholog of the human obesity gene FTO, affects food intake in rats. PLoS One. 2010;5:e8771.
61. McTaggart JS, Lee S, Iberl M, et al. FTO is expressed in neurons throughout the brain and its expression is unaltered by fasting. PLoS One. 2011;6:e27968.
62. Cheung MK, Gulati P, O'Rahilly S, et al. FTO expression is regulated by availability of essential amino acids. Int J Obes. 2013;37:744-7.
63. Gulati P, Cheung MK, Antrobus R, et al. Role for the obesity-related FTO gene in the cellular sensing of amino acids. Proc Natl Acad Sci U S A. 2013;110:2557-62.
64. Wang P, Yang FJ, Du H, et al. Involvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass- and obesity-associated (FTO) downregulation during energy restriction. Mol Med. 2011;17:523-32.
65. Rask-Andersen M, Almen MS, Olausen HR, et al. Functional coupling analysis suggests link between the obesity gene FTO and the BDNF-NTRK2 signaling pathway. BMC Neurosci. 2011;12:117.
66. Vujovic P, Stamenkovic S, Jasnic N, et al. Fasting induced cytoplasmic FTO expression in some neurons of rat hypothalamus. PLoS One. 2013;8:e63694.
67. •• Jia GF, Fu Y, Zhao X, et al. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nature Chem Biol. 2011;7:885-7. This finding unveiled the physiological RNA modification substrate, m6A, of FTO in vivo and in vitro for the first time.
68. Gerken T, Girard CA, Tung YC, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007;318:1469-72. (Pubitemid 350208961)
69. Jia G, Yang CG, Yang S, et al. Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Lett. 2008;582:3313-9.
70. Han Z, Niu T, Chang J, et al. Crystal structure of the FTO protein reveals basis for its substrate specificity. Nature. 2010;464:1205-9.
71. •• Meyer KD, Saletore Y, Zumbo P, et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell. 2012;149:1635-46. It is one of the 2 papers describing the genome-wide distribution of m6A sites in mRNAs. It further shows that m6A sites are enriched near stop codons and in 3′ UTRs.
72. Saletore Y, Meyer K, Korlach J, et al. The birth of the Epitranscriptome: deciphering the function of RNA modifications. Genome Biol. 2012;13:175.
73. Zheng G, Dahl JA, Niu Y, et al. Sprouts of RNA epigenetics: the discovery of mammalian RNA demethylases. RNA Biol. 2013;10.
74. Pan T. N6-methyl-adenosine modification in messenger and long non-coding RNA. Trends Biochem Sci. 2013;38:204-9.
75. 6A) in RNA: an old modification with a novel epigenetic function. Genomics Proteomics Bioinformatics. 2013;11:8-17.
76. Jia G, Fu Y, He C. Reversible RNA adenosine methylation in biological regulation. Trends Genet. 2013;29:108-15.
77. Fu Y, He C. Nucleic acid modifications with epigenetic significance. Curr Opin Chem Biol. 2012;16:516-24.
78. 6-formyladenosine in mammalian RNA. Nat Commun. 2013;4:1798. The authors uncovered new intermediate modifications in the demethylation process from m6A to A by FTO.
79. Wei CM, Gershowitz A, Moss B. Methylated nucleotides block 5′ terminus of HeLa cell messenger RNA. Cell. 1975;4:379-86.
80. Perry RP, Kelley DE, Friderici K, et al. The methylated constituents of L cell messenger RNA: evidence for an unusual cluster at the 5′ terminus. Cell. 1975;4:387-94.
81. Desrosiers RC, Friderici KH, Rottman FM. Characterization of Novikoff hepatoma mRNA methylation and heterogeneity in the methylated 5′ terminus. Biochemistry. 1975;14:4367-74.
82. 6A-seq. Nature. 2012;485:201-6. This is the first report on the landscape of m6A in mRNAs through an antibody-based genome-wide sequencing method.
83. Gulati P, Yeo GS. The biology of FTO: from nucleic acid demethylase to amino acid sensor. Diabetologia. 2013.
84. Bokar JA, Shambaugh ME, Polayes D, et al. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)- methyltransferase. RNA. 1997;3:1233-47. (Pubitemid 27495096)
85. Zheng G, Dahl JA, Niu Y, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49:18-29.
86. Liu J, Yue Y, Han D, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N-adenosine methylation. Nat Chem Biol. 2013;10:93-5.
87. Ping XL, Sun BF, Wang L, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24:177-89.
88. Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457-63. (Pubitemid 38715140)
89. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010;28:1057-68.
90. Baltz AG, Munschauer M, Schwanhausser B, et al. The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol Cell. 2012;46:674-90.
91. Vilfan ID, Tsai YC, Clark TA, et al. Analysis of RNA base modification and structural rearrangement by single-molecule real-time detection of reverse transcription. J Nanobiotechnology. 2013;11:8.
92. Clark TA, Lu X, Luong K, et al. Enhanced 5-methylcytosine detection in single-molecule, real-time sequencing via Tet1 oxidation. BMC Biol. 2013;11:4.
93. Song CX, Clark TA, Lu XY, et al. Sensitive and specific single-molecule sequencing of 5-hydroxymethylcytosine. Nat Methods. 2012;9:75-7.
94. Chen B, Ye F, Yu L, et al. Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am Chem Soc. 2012;134:17963-71.